RWM
UTHR icon

Ritholtz Wealth Management’s United Therapeutics UTHR Stock Holding History

Ritholtz Wealth Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03M Buy
1,905
+803
+73% +$452K 0.02% 608
2026
Q1 		$653K Sell
1,102
-28
-2% -$13.9K 0.01% 693
2025
Q4 		$551K Buy
1,130
+168
+17% +$78.2K 0.01% 691
2025
Q3 		$403K Sell
962
-113
-11% -$38K 0.01% 744
2025
Q2 		$309K Buy
1,075
+250
+30% +$74.7K 0.01% 784
2025
Q1 		$254K Hold
825
– – 0.01% 792
2024
Q4 		$291K Sell
825
-14
-2% -$5.15K 0.01% 717
2024
Q3 		$301K Buy
839
+105
+14% +$35.5K 0.01% 699
2024
Q2 		$234K Buy
+734
New +$194K 0.01% 724
2023
Q1 		– Sell
-1,026
Closed -$285K – 672
2022
Q4 		$285K Sell
1,026
-267
-21% -$67.4K 0.02% 465
2022
Q3 		$271K Buy
1,293
+120
+10% +$26.8K 0.01% 574
2022
Q2 		$276K Sell
1,173
-250
-18% -$50.8K 0.02% 429
2022
Q1 		$255K Sell
1,423
-1,237
-47% -$236K 0.02% 447
2021
Q4 		$575K Buy
2,660
+67
+3% +$13.2K 0.04% 271
2021
Q3 		$479K Buy
2,593
+517
+25% +$102K 0.03% 279
2021
Q2 		$372K Buy
2,076
+508
+32% +$96.8K 0.03% 322
2021
Q1 		$262K Buy
+1,568
New +$261K 0.02% 345

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Ritholtz Wealth Management's UTHR Position: Q2 2026 in Review

Ritholtz Wealth Management increased its United Therapeutics (UTHR) stake by 73% in Q2 2026, buying an estimated $452K and bringing the position to 1,905 shares worth $1.03M. The position accounts for 0.02% of the portfolio, ranked #608.

Ritholtz Wealth Management first reported a position in UTHR in Q1 2021 and has held it in 17 quarters since. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Ritholtz Wealth Management held 1,905 shares of United Therapeutics worth $1.03M as of Q2 2026.
  • Ritholtz Wealth Management bought 803 United Therapeutics shares in Q2 2026, an estimated $452K.
  • United Therapeutics made up 0.02% of Ritholtz Wealth Management's portfolio in Q2 2026, its #608 holding.
  • Ritholtz Wealth Management first reported a position in United Therapeutics in Q1 2021 and has held it in 17 quarters since.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Ritholtz Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.